It’s worth noting that CD4+ T cells identify distinct surface markers compared to CD8+ T cells, and given that cancer cells generally lack MHC-II expression, CD4+ T cells demonstrate effectiveness in exerting tumor suppression through interactions with stromal cell surface markers. This evidence concerns the gene CD8A and neoplasm.